Rankings
▼
Calendar
CAI FY 2005 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
FY 2005 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$62M
Gross Profit
$62M
100.0% margin
Operating Income
$24M
39.2% margin
Net Income
$10M
16.2% margin
EPS (Diluted)
$0.47
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$29M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$181M
Total Liabilities
$148M
Stockholders' Equity
$33M
Cash & Equivalents
$8M
← FY 2006
All Quarters